126 related articles for article (PubMed ID: 23479363)
21. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum ferritin in patients with renal cell carcinoma.
Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
[TBL] [Abstract][Full Text] [Related]
23. [Significance of plasma interleukin-6 in the diagnosis of renal cell carcinoma].
Kamemoto H
Hinyokika Kiyo; 1993 Apr; 39(4):301-6. PubMed ID: 8503325
[TBL] [Abstract][Full Text] [Related]
24. Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.
Hatakeyama S; Amano M; Tobisawa Y; Yoneyama T; Tsuchiya N; Habuchi T; Nishimura S; Ohyama C
J Urol; 2014 Mar; 191(3):805-13. PubMed ID: 24140550
[TBL] [Abstract][Full Text] [Related]
25. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative molecular serum analysis in renal cancer.
Gonzalgo ML; Eisenberger CF; Lee SM; Trock BJ; Marshall FF; Hortopan S; Sidransky D; Schoenberg MP
Clin Cancer Res; 2002 Jun; 8(6):1878-81. PubMed ID: 12060631
[TBL] [Abstract][Full Text] [Related]
27. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.
Tang SW; Yang TC; Lin WC; Chang WH; Wang CC; Lai MK; Lin JY
Carcinogenesis; 2011 Feb; 32(2):138-45. PubMed ID: 21045016
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
29. Tissue polypeptide specific antigen (TPS) as a tumor marker in renal cell carcinoma.
Chang CH; Wu HC; Yen RF; Kao A; Lin CC; Lee CC
Anticancer Res; 2002; 22(5):2949-50. PubMed ID: 12530023
[TBL] [Abstract][Full Text] [Related]
30. Nicotinamide N-methyltransferase protein expression in renal cell cancer.
Zhang J; Xie XY; Yang SW; Wang J; He C
J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648
[TBL] [Abstract][Full Text] [Related]
31. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
32. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
Kaya K; Ayan S; Gokce G; Kilicarslan H; Yildiz E; Gultekin EY
Scand J Urol Nephrol; 2005; 39(1):25-9. PubMed ID: 15764267
[TBL] [Abstract][Full Text] [Related]
33. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
34. Nicotinamide N-methyltransferase in non-small cell lung cancer: promising results for targeted anti-cancer therapy.
Sartini D; Morganti S; Guidi E; Rubini C; Zizzi A; Giuliante R; Pozzi V; Emanuelli M
Cell Biochem Biophys; 2013; 67(3):865-73. PubMed ID: 23532607
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.
Tomida M; Mikami I; Takeuchi S; Nishimura H; Akiyama H
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1223-9. PubMed ID: 19242722
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
[TBL] [Abstract][Full Text] [Related]
37. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
[TBL] [Abstract][Full Text] [Related]
38. How do symptoms have an impact on the prognosis of renal cell carcinoma?
Kawata N; Nagane Y; Yamaguchi K; Ichinose T; Hirakata H; Takahashi S
Int J Urol; 2008 Apr; 15(4):299-303. PubMed ID: 18380815
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
40. CD70: a new tumor specific biomarker for renal cell carcinoma.
Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
